Evidence map›Paper›PMID 34601646›Full record

ArticleAnnals of intensive care2021

Long-term survival of mechanically ventilated patients with severe COVID-19: an observational cohort study.

Oscar Peñuelas, Laura Del Campo-Albendea, Amanda Lesmes González de Aledo, José Manuel Añón, Carmen Rodríguez-Solís, Jordi Mancebo, Paula Vera, Daniel Ballesteros, Jorge Jiménez, Emilio Maseda and 22 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04379258 (Epidemiological Analysis of the Mortality of Critically Ill Patients With the COVID-19 Admitted to the Intensive Care Unit), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04379258 completednot on this map

Epidemiological Analysis of the Mortality of Critically Ill Patients With the COVID-19 Admitted to the Intensive Care Unit: An Observational, Prospective and Multicenter Study

Typeobservational_patient_registrySponsorHospital Universitario GetafeRan2021 to 2021Enrolled868ConditionsCOVID-19, Critical Illness, Effectiveness, Outcome, Fatal
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Impact of frailty on long-term survival in patients discharged alive from hospital after an ICU admission with COVID-19.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2024
    Article
  6. Frailty in Critically Ill Patients with COVID-19: The Lessons Learned.Advances in experimental medicine and biology · 2024
    Review
  7. The impact of body mass index on long-term survival after ICU admission due to COVID-19: A retrospective multicentre study.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Delayed mortality among solid organ transplant recipients hospitalized for COVID-19.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 17 institutions in 1 country.

Oscar PeñuelasIntensive Care Unit, Hospital Universitario de Getafe, Carretera de Toledo km 12,500, 28905, Madrid, Spain. openuelas@gmail.com.ORCID http://orcid.org/0000-0003-1484-3933
Laura Del Campo-AlbendeaDepartment of Clinical Biostatistics, Hospital Ramón Y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria & Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública, Madrid, Spain.
Amanda Lesmes González de AledoIntensive Care Unit, Hospital Universitario Doce de Octubre, Madrid, Spain.
José Manuel AñónCentro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Carmen Rodríguez-SolísIntensive Care Unit, Hospital Universitario de Getafe, Carretera de Toledo km 12,500, 28905, Madrid, Spain.
Jordi ManceboIntensive Care Unit, Hospital Universitari Sant Pau, Barcelona, Spain.
Paula VeraIntensive Care Unit, Hospital Universitari Sant Pau, Barcelona, Spain.
Daniel BallesterosIntensive Care Unit, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Jorge JiménezIntensive Care Unit, Hospital Universitario de Getafe, Carretera de Toledo km 12,500, 28905, Madrid, Spain.
Emilio MasedaDepartment of Anesthesiology and Critical Care, Hospital Universitario La Paz, Madrid, Spain.
Juan Carlos FigueiraCentro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Nieves FrancoIntensive Care Unit, Hospital Universitario de Móstoles, Madrid, Spain.
Ángela AlgabaIntensive Care Unit, Hospital Universitario de Torrejón, Madrid, Spain.
Juan Pablo AvilésIntensive Care Unit, Hospital Universitario Severo Ochoa, Leganés, Spain.
Ricardo DíazIntensive Care Unit, Hospital Universitario Severo Ochoa, Leganés, Spain.
Beatriz AbadIntensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain.
Alfonso CanabalIntensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain.
Ana AbellaIntensive Care Unit, Hospital Universitario del Henares, Coslada, Spain.
Federico GordoIntensive Care Unit, Hospital Universitario del Henares, Coslada, Spain.
Javier GarcíaDepartment of Anesthesiology and Critical Care, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Jessica García SuarezDepartment of Anesthesiology and Critical Care, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Jamil CedeñoIntensive Care Unit, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Basilia Martínez-PalaciosIntensive Care Unit, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
Eva ManteigaIntensive Care Unit, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain.
Óscar MartínezIntensive Care Unit, Hospital Universitario del Tajo, Aranjuez, Madrid, Spain.
Rafael BlancasIntensive Care Unit, Hospital Universitario del Tajo, Aranjuez, Madrid, Spain.
Tommaso BardiDepartment of Anesthesiology and Critical Care, Hospital Universitario Ramón Y Cajal, Madrid, Spain.
David PestañaDepartment of Anesthesiology and Critical Care, Hospital Universitario Ramón Y Cajal, Madrid, Spain.
José Ángel LorenteIntensive Care Unit, Hospital Universitario de Getafe, Carretera de Toledo km 12,500, 28905, Madrid, Spain.
Alfonso MurielDepartment of Clinical Biostatistics, Hospital Ramón Y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria & Centro de Investigación Biomédica en Red de Epidemiología Y Salud Pública, Madrid, Spain.
Andrés EstebanIntensive Care Unit, Hospital Universitario de Getafe, Carretera de Toledo km 12,500, 28905, Madrid, Spain.
Fernando Frutos-VivarIntensive Care Unit, Hospital Universitario de Getafe, Carretera de Toledo km 12,500, 28905, Madrid, Spain.
Hospital Universitario de Getafe · ESHospital Universitario La Paz · ESHospital Universitario Puerta de Hierro Majadahonda · ESCentro de Investigación Biomédica en Red · ESHospital de Sant Pau · ESHospital Universitario de La Princesa · ESHospital Universitario del Henares · ESHospital Universitario del Tajo · ESHospital Universitario Infanta Cristina · ESHospital Universitario Ramón y Cajal · ESHospital Universitario Severo Ochoa · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario 12 De Octubre · ESHospital Universitario de Móstoles · ESHospital Universitario de Torrejón · ESInstituto de Salud Carlos III · ES

Funding

Instituto de Salud Carlos III Foundation for Biomedical Research of the University Hospital of Getafe, Spain (COVID-19 No.ISCIII:COV20/00977, 2020. Madrid (0010604)
6 · The paper itself

Abstract

backgroundInformation is lacking regarding long-term survival and predictive factors for mortality in patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19) and undergoing invasive mechanical ventilation. We aimed to estimate 180-day mortality of patients with COVID-19 requiring invasive ventilation, and to develop a predictive model for long-term mortality.

methodsRetrospective, multicentre, national cohort study between March 8 and April 30, 2020 in 16 intensive care units (ICU) in Spain. Participants were consecutive adults who received invasive mechanical ventilation for COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection detected in positive testing of a nasopharyngeal sample and confirmed by real time reverse-transcriptase polymerase chain reaction (rt-PCR). The primary outcomes was 180-day survival after hospital admission. Secondary outcomes were length of ICU and hospital stay, and ICU and in-hospital mortality. A predictive model was developed to estimate the probability of 180-day mortality.

results868 patients were included (median age, 64 years [interquartile range [IQR], 56-71 years]; 72% male). Severity at ICU admission, estimated by SAPS3, was 56 points [IQR 50-63]. Prior to intubation, 26% received some type of noninvasive respiratory support. The unadjusted overall 180-day survival rates was 59% (95% CI 56-62%). The predictive factors measured during ICU stay, and associated with 180-day mortality were: age [Odds Ratio [OR] per 1-year increase 1.051, 95% CI 1.033-1.068)), SAPS3 (OR per 1-point increase 1.027, 95% CI 1.011-1.044), diabetes (OR 1.546, 95% CI 1.085-2.204), neutrophils to lymphocytes ratio (OR per 1-unit increase 1.008, 95% CI 1.001-1.016), failed attempt of noninvasive positive pressure ventilation prior to orotracheal intubation (OR 1.878 (95% CI 1.124-3.140), use of selective digestive decontamination strategy during ICU stay (OR 0.590 (95% CI 0.358-0.972) and administration of low dosage of corticosteroids (methylprednisolone 1 mg/kg) (OR 2.042 (95% CI 1.205-3.460).

conclusionThe long-term survival of mechanically ventilated patients with severe COVID-19 reaches more than 50% and may help to provide individualized risk stratification and potential treatments.

trial registrationClinicalTrials.gov Identifier: NCT04379258. Registered 10 April 2020 (retrospectively registered).

Indexed as

ARDSCoronavirus disease 2019COVID-19Intensive care unitInvasive mechanical ventilationMortalityNoninvasive ventilationPneumoniaSARS-CoV-2

Identifiers

PMID34601646
PMCPMC8487336
OpenAlexW3157445899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.